Information Provided By: 
Fly News Breaks for March 29, 2019
CL
Mar 29, 2019 | 06:50 EDT
UBS analyst Steven Strycula raised his price target on Colgate-Palmolive to $75 and kept his Buy rating. The analyst believes that the market "underappreciates" the company's ability to boost its prices over the long term. Strycula also anticipates Colgate-Palmolive to benefit as it "penetrates premium segments in developed markets and increases trade-up and brushing use in emerging markets," even as he sees its oral care portfolio "priced at a 12% value discount."
News For CL From the Last 2 Days
There are no results for your query CL
